InMed Pharmaceuticals Inc. INM
15.56 USD +2.55 (+19.65%)
Regular-session close
14.58 -0.98 -6.30%
After hours · Nov 6, 4:00 PM ET
13.70 Day range 16.44
5.75 52-week range 23.30
- YTD
- +46.79%
- 1 year
- -10.57%
News
benzinga.com Guggenheim Initiates Coverage On InMed Pharmaceuticals with Buy Rating, Announces Price Target of $42 Guggenheim analyst Seamus Fernandez initiates coverage on InMed Pharmaceuticals (NASDAQ:INM) with a Buy rating and announces Price Target of $42.
benzinga.com InMed Pharmaceuticals Q1 EPS $(0.36) Up From $(0.46) YoY InMed Pharmaceuticals (NASDAQ:INM) reported quarterly losses of $(0.36) per share. This is a 21.74 percent increase over losses of $(0.46) per share from the same period last year.
